Skip to main content

Current Duke Appointments & Affiliations


Associate Professor in Medicine · 2025 - Present Medicine, Endocrinology, Metabolism, and Nutrition, Medicine
Associate Research Professor in Pharmacology & Cancer Biology · 2021 - Present Pharmacology & Cancer Biology, Basic Science Departments
Member of Duke Molecular Physiology Institute · 2015 - Present Duke Molecular Physiology Institute, Institutes and Centers

Recent News Items


Published July 8, 2026
The Next Generation of Obesity Drugs

View All News Items

Recent Scholarly Works


Primary cilia regulate GLP-1 signaling in pancreatic β cells.

Journal article Mol Metab · May 2026 Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are mainstay therapies for diabetes and obesity, acting in part by enhancing glucose-dependent insulin secretion. While the primary cilium is a known signaling compartment for certain G-protein coupled r ... Full text Link to item Cite

GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.

Journal article Nature · May 2026 There are increasing numbers of effective drugs to improve obesity-linked metabolic dysfunction; GLP-1R-GIPR co-agonism is effective in the management of obesity and type 2 diabetes1,2, and lanifibranor-a nuclear-acting small-molecule triple agonist of PPA ... Full text Link to item Cite

Glucagon promotes net hepatic glycogen repletion following meal ingestion.

Journal article JCI Insight · April 22, 2026 Insulin and glucagon are described as having opposing actions on hepatic glycogen metabolism. However, here we showed that their coordinated action promoted glycogen turnover and meal glucose storage. In mice, pharmacological doses of insulin or glucagon f ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Cell and Molecular Biology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institute of General Medical Sciences · 2026 - 2031

Metabolic Actions of Glucagon

ResearchPrincipal Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2025 - 2030

Regulation of Adipose Tissue Plasticity by Pericyte GIPR

ResearchPrincipal Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2025 - 2030

View All Grants

Education


York University in Toronto (Canada) · 2010 Ph.D.